MYCN amplification is frequently observed in neuroblastoma primary tumors and cell lines, and MYCN over-expression has been shown to drive tumorigenesis in a transgenic mouse model when placed under the control of the TH promoter [41]. Here, MYCN is linked to neuroblastoma.